Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCM-CD (#RDB01696)

E. coli Cytosine deaminase

Alternative name CM-cytosine deaminase
Clone info. CD (cytosine deaminase) under regulation with CM promoter
Comment NtTA has been removed at the construction of this plasmid.
Vector backbone pCM-NtTA (Plasmid)
Size of vector backbone 3,875 bp
Selectable markers Amp^r
Gene/insert name E. coli Cytosine deaminase (CD) Genomic DNA
Depositor|Developer Hamada, Hirofumi |
 
Additional map

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(J. Leukoc. Biol., 60, 181-190 (1996).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(J. Leukoc. Biol., 60, 181-190 (1996).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB01696 pCM-CD DNA solution Please contact us.

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCM-CD was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01696).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB13438_A5Fi.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward
Sequence file: RDB13438_A5Fia.seq check
>01696_13438_A5Fi_CMV-Forward_F04_16.ab1
    1 TGTCACTCCG CCCATTGACG CAATGGGCGG TAGGCGTGTA CGGTGGGAGG TCTATATAAG
   61 CAGAGCTCGT TTAGTGAACC GTCAGATCGC CTGGAGACGC CATCCACGCT GTTTTGACCT
  121 CCATAGAAGA CACCGGGACC GATCCAGCCT CCGCGGCCCC GAATTCCGGG GATCCACCAT
  181 GTCGAATAAC GCTTTACAAA CAATTATTAA CGCCCGGTTA CCAGGCGAAG AGGGGCTGTG
  241 GCAGATTCAT CTGCAGGACG GAAAAATCAG CGCCATTGAT GCGCAATCCG GCGTGATGCC
  301 CATAACTGAA AACAGCCTGG ATGCCGAACA AGGTTTAGTT ATACCGCCGT TTGTGGAGCC
  361 ACATATTCAC CTGGACACCA CGCAAACCGC CGGACAACCG AACTGGAATC AGTCCGGCAC
  421 GCTGTTTGAA GGCATTGAAC GCTGGGCCGA GCGCAAAGCG TTATTAACCC ATGACGATGT
  481 GAAACAACGC GCATGGCAAA CGCTGAAATG GCAGATTGCC AACGGCATTC AGCATGTGCG
  541 TACCCATGTC GATGTTTCGG ATGCAACGCT AACTGCGCTG AAAGCAATGC TGGAAGTGAA
  601 GCAGGAAGTC GCGCCGTGGA TTGATCTGCA AATCGTCGCC TTCCCTCAGG AAGGGATTTT
  661 GTCGTATCCC AACGGTGAAG CGTTGCTGGA AGAGGCGTTA CGCTTAGGGG CAGATGTAGT
  721 GGGGGCGATT CCGCATTTTG AATTTACCCG TGAATACGGC GTGGAGTCGC TGCATAAAAC
  781 CTTCGCCCTG GCGCAAAAAT ACGACCGTCT CATCGACGTT CACTGTGATG AGATCGATGA
  841 CGAGCAGTCG CGCTTTGTCG AAACCGTTGC TGCCCTGGCG CACCATGAAG GCATGGGCGC
  901 GCGAGTCACC GCCAGCCACA CCACGGCAAT GCACTCCTAT AACGGGGCGT ATACCTCACG
  961 CCTGTTCCGC TTGCTGAAAA TGTCCGGTAT TAACTTTGTC GCCCAACCCG CTGGTCATAT
 1021 TCATCTGCAA GGACGTTTCG ATACGTATCC CAAAACGTCG CGGCATCACG CCGCGTTAAG
 1081 AAGATGCTGG AGTCCGGGCA TTAACGGTCT GCCTTGGTCA CGGAATGGAT GGTCTTTCGA
1141 TCCGATGGTA TCCCGCTGGG AACCGGGCCA AT
//
Primer: pAxCALNL_F1
Sequence file: RDB13438_A5Fib.seq check
>01696_13438_A5Fi_pAxCALNL_F1_F09_18.ab1
    1 ATATCTATCT TATCATGTCT GGATCTCAGT GGTATTTGTG AGCCAGGGCA TTGGCCACAC
   61 CAGCCACCAC CTTCTGATAG GCAGCCTGCA CCTGAGGAGT GAATTCCTAC GAGTTCAGTG
  121 CTCTACGTAG GCCGGATAAG GCGTTCACGC CGCATCCGGC ATAAACTAAG CTCGCTGTAA
  181 CCCAGTCGTT CAACGTTTGT AATCGATGGC TTCTGGCTGC TCCAGATATA CGGTGGTTTG
  241 TGCCGGTTGT GTGCTGGCAA TCACCTTGCC GCCACGTACC GAATAACGTA CCGGAACCTG
  301 ACGGCGCAGC GCATCAAACC CATTTTCAGC CGGCAGGATA ATCAGGTTGG CGCTGTTTCC
  361 GGCGGCAATG CCGTAATCCT GCAAATTCAA CGTCCTTGCG CTGTGGTGGG TGATTAAATT
  421 CAGGCCATCG TTAATCTGCC CGTAGCCCAT CAACTGGCAA ACATGCAGCC CCATATGCAG
  481 CACTTGCAGC ATATTCGCCG TTCCCAGCGG ATACCACGGA TCGAAGACAT CATCGTGACC
  541 AAAGCAGACG TTAATGCCGG ACTCCAGCAT CTCTTTAACG CGCGTGATGC CGCGACGTTT
  601 TGGATACGTA TCGAAACGTC CTTGCAGATG AATATTGACC AGCGGGTTGG CGACAAAGTT
  661 AATACCGGAC ATTTTCAGCA AGCGGAACAG GCGTGAGGTA TACGCCCCGT TATAGGAGTG
  721 CATTGCCGTG GTGTGGCTGG CGGTGACTCG CGCGCCCATG CCTTCATGGT GCGCCAGGGC
  781 AGCAACGGTT TCGACAAAGC GCGACTGCTC GTCATCGATC TCATCACAGT GAACGTCGAT
  841 GAGACGGTCG TATTTTTGCG CCAGGGCGAA GGTTTTATGC AGCGACTCCA CGCCGTATTC
  901 ACGGGTAAAT TCAAAATGCG GAATCGCCCC CACTACATCT GCCCCTAAGC GTAACGCCTC
  961 TTCCAGCAAC GCTTCACCGT TGGGATACGA CAAAATCCCT TCCTGAGGGA AGGCGACGAT
 1021 TTGCAGATCA ATCCACGGCG CGACTTCCTG CTTCACTTCC AGCAATGCTT TCAGCGCAGT
 1081 TAGCGTTGCA TCCGAAACAT CGACATGGGT ACGCACATGC CTGATGCGTA GCATCTGGCC
1141 CATTTCAGCG ATTGCCAATG GCGCGGTGGT TTCACACACT CGCGCTCCAA TTG
//
Primer: SV40pA3'Element Reverse
Sequence file: RDB13438_A5Fic.seq check
>01696_13438_A5Fi_SV40pA3'ElementReverse_D12_12.ab1
    1 GTGTCAGGGG CGGAGCCTAT GGAAACGCCA GCAACGCGGC CTTTTTACGG TTCCTGGCCT
   61 TTTGCTGGCC TTTTGCTCAC ATGTTCTTTC CTGCGTTATC CCCTGATTCT GTGGATAACC
  121 GTATTACCGC CTTTGAGTGA GCTGATACCG CTCGCCGCAG CCGAACGACC GAGCGCAGCG
  181 AGTCAGTGAG CGAGGAAGCG GAAGAGCGCC CAATACGCAA ACCGCCTCTC CCCGCGCGTT
  241 GGCCGATTCA TTAATGCAGC TGAACGGTCT GGTTATAGGT ACATTGAGCA ACTGACTGAA
  301 ATGCCTCAAA ATGTTCTTTA CGATGCCATT GGGATATATC AACGGTGGTA TATCCAGTGA
  361 TTTTTTTCTC CATTTTAGCT TCCTTAGCTC CTGAAAATCT CGCCAAGCTT GGTCGAGCTG
  421 GATACTTCCC GTCCGCCAGG GGGACATGCC GGCGATGCTG AAGGTCGCGC GCATTCCCGA
  481 TGAAGAGGCC GGTTACCGCC TGTTGACCTG GTGGGACGGG CAGGGCGCCG CCCGAGTCTT
  541 CGCCTCGGCG GCGGGCGCTC TGCTCATGGA GCGCGCGTCC GGGGCCGGGG ACCTTGCACA
  601 GATAGCGTGG TCCGGCCAGG ACGACGAGGC TTGCAGGATC ATAATCAGCC ATACCACATT
  661 TGTAGAGGTT TTACTTGCTT TAAAAAACCT CCCACACCTC CCCCTGAACC TGAAACATAA
  721 AATGAATGCA ATTGTTGTTG TTAACTTGTT TATTGCAGCT TATAATGGTT ACAAATAAAG
  781 CAATAGCATC ACAAATTTCA CAAATAAAGC ATTTTTTTCA CTGCATTCTA GTTGTGGTTT
  841 GTCCAAACTC ATCAATGTAT CTTATCATGT CTGGATCTCA GTGGTATTTG TGAGCCAGGG
  901 CATTGGCCAC ACCAGCCACC ACCTTCTGAT AGGCAGCCTG CACCTGAGGA GTGAATTCCT
  961 ACGAGTTCAG TGCTCTACGT AGGCCGGATA AAGGCGTTCA CGCCGCATCC GGGCATAAAC
 1021 TAAGCTCGCT GTAACCCAGT CGTTTCAACG TTTGTAATCG ATGGCTTCTG GCTGCTCCAG
 1081 ATATACGGTG ATTGTGCCGC TGTGTGCTGG CAATCACGTG GCGGCACGTA CGATACGTTA
1141 CCCGGAACCC TGACGGCGCA GGCGCCAATT CAAACCCCAA TT
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles